Anavex Life Sciences
AVXL
#7563
Rank
S$0.50 B
Marketcap
S$5.70
Share price
-1.12%
Change (1 day)
-47.67%
Change (1 year)

Anavex Life Sciences (AVXL) - Cash on Hand

Cash on Hand as of June 2025 : S$0.13 Billion

According to Anavex Life Sciences 's latest financial reports the company has S$0.13 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Anavex Life Sciences - Cash on Hand chart (from 2005 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-09-30S$0.16 B-17.66%
2023-09-30S$0.20 B-3.64%
2022-09-30S$0.21 B3.63%
2021-09-30S$0.20 B417.58%
2020-09-30S$39.91 M30.17%
2019-09-30S$30.66 M-2.2%
2018-09-30S$31.35 M-15.93%
2017-09-30S$37.29 M197.56%
2016-09-30S$12.53 M-42.42%
2015-09-30S$21.76 M134.91%
2014-09-30S$9.26 M2039.31%
2013-09-30S$0.43 M3001.81%
2012-09-30S$0.01 M-92.02%
2011-09-30S$0.17 M-49.74%
2010-09-30S$0.34 M-29.93%
2009-09-30S$0.49 M5339.15%
2008-09-30S$0 M24649.42%
2007-09-30S$0 M-99.81%
2006-09-30S$0.01 M1080.43%
2005-09-30S$0 M-96.5%
2004-09-30S$0.04 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Ligand Pharmaceuticals
LGND
S$0.87 B 569.15%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
S$0.27 B 110.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
S$0.54 B 316.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
S$3.26 M-97.51%๐Ÿ‡บ๐Ÿ‡ธ USA